JPS6011903B2 - ピリドキシン誘導体 - Google Patents

ピリドキシン誘導体

Info

Publication number
JPS6011903B2
JPS6011903B2 JP54096889A JP9688979A JPS6011903B2 JP S6011903 B2 JPS6011903 B2 JP S6011903B2 JP 54096889 A JP54096889 A JP 54096889A JP 9688979 A JP9688979 A JP 9688979A JP S6011903 B2 JPS6011903 B2 JP S6011903B2
Authority
JP
Japan
Prior art keywords
acid
propionic acid
formula
trifluoromethyl
phenylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54096889A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5536483A (en
Inventor
アルベルト・ライナ−
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KURINOSU IND FUARUMAKOBIOROJIKA SpA
Original Assignee
KURINOSU IND FUARUMAKOBIOROJIKA SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KURINOSU IND FUARUMAKOBIOROJIKA SpA filed Critical KURINOSU IND FUARUMAKOBIOROJIKA SpA
Publication of JPS5536483A publication Critical patent/JPS5536483A/ja
Publication of JPS6011903B2 publication Critical patent/JPS6011903B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • C07D213/67—2-Methyl-3-hydroxy-4,5-bis(hydroxy-methyl)pyridine, i.e. pyridoxine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP54096889A 1978-07-31 1979-07-31 ピリドキシン誘導体 Expired JPS6011903B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT26327A/78 1978-07-31
IT26327/78A IT1097601B (it) 1978-07-31 1978-07-31 Derivati della piridosina ad attivita' farmacologica
IT22932A/79 1979-05-23

Publications (2)

Publication Number Publication Date
JPS5536483A JPS5536483A (en) 1980-03-14
JPS6011903B2 true JPS6011903B2 (ja) 1985-03-28

Family

ID=11219237

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54096889A Expired JPS6011903B2 (ja) 1978-07-31 1979-07-31 ピリドキシン誘導体

Country Status (3)

Country Link
JP (1) JPS6011903B2 (it)
BE (1) BE877953A (it)
IT (1) IT1097601B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1133963B (it) * 1980-10-21 1986-07-24 D & D Srl Derivati piridossinici ad attivita' terapeutica,procedimento per la loro preparazione e relative composizioni farmaceutiche
RU2629367C1 (ru) * 2016-11-02 2017-08-29 федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) Нестероидное противовоспалительное средство на основе напроксена, обладающее низкой гастротоксичностью

Also Published As

Publication number Publication date
JPS5536483A (en) 1980-03-14
IT7826327A0 (it) 1978-07-31
BE877953A (fr) 1979-11-16
IT1097601B (it) 1985-08-31

Similar Documents

Publication Publication Date Title
JPH05502452A (ja) チロシンキナーゼ阻害剤としてのベンジルホスホン酸
US3642785A (en) Indenyl-3-aliphatic amines
US4882349A (en) Pyrrolacetic amides having antiinflammatory activity
JP2870925B2 (ja) 脂肪族２‐ヒドロキシ酸と１‐ベンジル‐３‐ヒドロキシメチル‐インダゾールのエーテル
JPS6037095B2 (ja) ピペラジン置換体の製法
JP2006512372A (ja) ４−ニトロ−２−［（４’−メトキシ）−フェノキシ］−メタンスルホニルアニリン誘導体及びその医薬のための使用
US4011328A (en) Derivatives of pyridine-3-acetic acid, process for their preparation and applications thereof
CA1230127A (en) Phenylalkanoic acid derivatives, their preparation and use
JPH0215048A (ja) ネオペンチルエステル誘導体、その製造法およびその医薬としての使用
US4233304A (en) Pyridoxine derivatives
CA1139763A (fr) Procede d'obtention de nouveaux aryltrifluoroethanols
JPS5877849A (ja) ビフエニルアルキルカルボン酸エステル誘導体、その製造法及びこれを含む医薬
JPS6055069B2 (ja) １−フェニル−シクロペンタンカルボン酸のｎ−ピリジル−アミド、その製造法ならびにそれを有効成分とする消炎および鎮咳剤
JPH0251914B2 (it)
US4115394A (en) Amino derivatives of 6-phenylpyrazolo[3,4-b]pyridines
EP0155524B1 (en) -omega-aryl-alkylthienyl compounds, process for their preparation and pharmaceutical products containing these compounds
EP0083222B1 (en) New quinolylacetic acid compounds and pharmaceutical compositions containing them
JPH10502050A (ja) 骨関節疾患の治療に有用なｎ−〔｛４，５−ジヒドロキシ−及び４，５，８−トリヒドロキシ−９，１０−ジヒドロ−９，１０−ジオキソ−２−アントラセン−イル｝カルボニル〕アミノ酸
EP0079639B1 (en) A new anti-inflammatory drug
JPS63295539A (ja) 置換ビフェニル誘導体
US4461912A (en) Phenylacetic acid derivatives, their preparation and compositions containing them
CS216207B2 (en) Method of making the derivatives of the 1,4-diphenylpyrazole
US4532249A (en) Derivatives of p-acylaminophenol having a therapeutic action, and compositions having a therapeutic action containing said derivatives as pharmacologically active ingredients
US4243665A (en) 2-Heterocyclylalkyl-6-methoxy-naphthalenes
US4942176A (en) N-substituted aminoalkanoic acids, a process for their preparation, their use and pharmaceutical products based on these compounds